Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Planned sale Chief Executive Officer sold 60,218 shares at an average $303.18 ($18,256,808)
  2. 4 Planned sale SVP, General Counsel sold 664 shares at $302.46 ($200,833)
  3. 4 Open-market sale President and COO sold 1,292 shares at $276.26 ($356,927)
  4. 4 Open-market sale Chief Executive Officer sold 3,410 shares at an average $273.78 ($933,592)
  5. 4 Open-market sale President, Global Head of R&D sold 1,068 shares at $276.74 ($295,553)
  6. 4 Open-market sale President and COO sold 1,357 shares at $266.76 ($361,997)
  7. 4 Open-market sale Chief Executive Officer sold 3,693 shares at an average $265.55 ($980,686)
  8. 4 Open-market sale SVP, General Counsel sold 590 shares at $265.98 ($156,925)
  9. 4 Open-market sale President, Global Head of R&D sold 1,169 shares at $265.39 ($310,236)
  10. 4 Open-market sale Principal Accounting Officer sold 169 shares at an average $257.20 ($43,467)
  11. 4 Open-market sale President, Global Head of R&D sold 756 shares at $261.00 ($197,318)
  12. 4 Open-market sale Chief Financial Officer sold 631 shares at $257.74 ($162,637)
  13. 4 Open-market sale President and COO sold 626 shares at $261.20 ($163,512)
  14. 4 Open-market sale SVP, General Counsel sold 428 shares at $257.64 ($110,268)
  15. 4 Open-market sale Chief Executive Officer sold 1,949 shares at an average $257.24 ($501,355)
  16. 4 Grant or award Director acquired 99,892 shares (grant or award)
  17. 4 Grant or award Director acquired 18,980 shares (grant or award)
  18. 4 Grant or award Director acquired 18,980 shares (grant or award)
  19. 4 Grant or award Director acquired 18,980 shares (grant or award)
  20. 4 Grant or award Director acquired 18,980 shares (grant or award)

Page 2 of 29 · 580 filings